-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Horizon Therapeutics Public Ltd Co quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q2 2023.
- Horizon Therapeutics Public Ltd Co Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2023 was 234M shares, a 0.95% decline year-over-year.
- Horizon Therapeutics Public Ltd Co annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 235M shares, a 0.19% decline from 2021.
- Horizon Therapeutics Public Ltd Co annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 236M shares, a 9.46% increase from 2020.
- Horizon Therapeutics Public Ltd Co annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 215M shares, a 4.91% increase from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)